GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cellid Co Ltd (XKRX:299660) » Definitions » Institutional Ownership

Cellid Co (XKRX:299660) Institutional Ownership : 0.00% (As of Dec. 14, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Cellid Co Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Cellid Co's institutional ownership is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Cellid Co's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Cellid Co's Float Percentage Of Total Shares Outstanding is 0.00%.


Cellid Co Institutional Ownership Historical Data

The historical data trend for Cellid Co's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cellid Co Institutional Ownership Chart

Cellid Co Historical Data

The historical data trend for Cellid Co can be seen below:

2022-12-31 2023-01-31 2023-02-28 2023-03-31 2023-04-30 2023-05-31 2023-06-30 2023-07-31 2023-08-31 2023-09-30
Institutional Ownership 3.00 2.82 2.26 1.70 1.10 1.08 1.07 1.07 1.07 0.42

Cellid Co Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Cellid Co Business Description

Traded in Other Exchanges
N/A
Address
1 Gwanak-ro, Gwanak-gu, 142 Suite 504, Korea Seoul National University Building, seoul, KOR, 08826
Cellid Co Ltd is a research and development bioventure company. The company is developing immunotherapeutic vaccines, CeliVax. The CeliVax is a personalized vaccine which uses patient's own cells.

Cellid Co Headlines

No Headlines